Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Bond Biosciences, Inc. is a privately held, clinical stage biopharmaceutical company focused on the discovery and development of first-in-class non-absorbed oral therapeutics that bind excess ions locally in the gastrointestinal (GI) tract to treat or prevent human disease. Our clinical lead, BBI-001, was designed to be a safe, convenient, and effective treatment for sufferers of iron overload associated with Hereditary Hemoc...
Bond Biosciences, Inc. is a privately held, clinical stage biopharmaceutical company focused on the discovery and development of first-in-class non-absorbed oral therapeutics that bind excess ions locally in the gastrointestinal (GI) tract to treat or prevent human disease. Our clinical lead, BBI-001, was designed to be a safe, convenient, and effective treatment for sufferers of iron overload associated with Hereditary Hemochromatosis. By binding dietary iron to inhibit absorption.

List your booth number for exhibitions, ask us